CINECA IRIS Institutional Research Information System

ARESU, Luca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.222
EU - Europa 3.344
AS - Asia 1.948
SA - Sud America 146
OC - Oceania 96
AF - Africa 55
Continente sconosciuto - Info sul continente non disponibili 4
Totale 11.815
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.110
IT - Italia 1.143
CN - Cina 723
IE - Irlanda 487
SG - Singapore 473
FR - Francia 275
SE - Svezia 271
DE - Germania 265
GB - Regno Unito 175
JP - Giappone 171
VN - Vietnam 146
FI - Finlandia 142
UA - Ucraina 139
PL - Polonia 122
KR - Corea 115
BR - Brasile 98
AU - Australia 92
CA - Canada 86
ID - Indonesia 84
IN - India 73
AT - Austria 52
ES - Italia 49
TW - Taiwan 48
BE - Belgio 35
NL - Olanda 35
HK - Hong Kong 33
SN - Senegal 30
GR - Grecia 28
MX - Messico 24
TH - Thailandia 24
RU - Federazione Russa 23
TR - Turchia 23
RO - Romania 22
PT - Portogallo 20
CH - Svizzera 18
AR - Argentina 13
CL - Cile 13
DK - Danimarca 9
CO - Colombia 8
CZ - Repubblica Ceca 8
IL - Israele 8
IR - Iran 8
NG - Nigeria 8
RS - Serbia 8
PE - Perù 6
SA - Arabia Saudita 6
HU - Ungheria 5
UY - Uruguay 5
CI - Costa d'Avorio 4
NZ - Nuova Zelanda 4
ZA - Sudafrica 4
A2 - ???statistics.table.value.countryCode.A2??? 3
LT - Lituania 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
AO - Angola 2
BY - Bielorussia 2
DZ - Algeria 2
EC - Ecuador 2
EE - Estonia 2
EG - Egitto 2
GE - Georgia 2
NO - Norvegia 2
SI - Slovenia 2
BD - Bangladesh 1
CY - Cipro 1
ET - Etiopia 1
EU - Europa 1
GT - Guatemala 1
HR - Croazia 1
LA - Repubblica Popolare Democratica del Laos 1
MA - Marocco 1
MM - Myanmar 1
MY - Malesia 1
PH - Filippine 1
PR - Porto Rico 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
VE - Venezuela 1
Totale 11.815
Salva come PNG Salva come JPEG
Città #
Chandler 560
Santa Clara 525
Fairfield 499
Dublin 485
Singapore 379
Beijing 357
Torino 354
Houston 319
Ashburn 257
Woodbridge 252
Wilmington 229
Ann Arbor 219
Redwood City 215
Seattle 207
Cambridge 164
Columbus 157
Medford 149
Villeurbanne 141
Princeton 133
Nyköping 132
Pisa 118
Jacksonville 115
Dong Ket 97
Warsaw 97
Jakarta 75
Turin 73
Dearborn 70
Milan 54
Tokyo 54
Guangzhou 43
San Diego 40
Vienna 40
Boston 38
Sydney 36
Nanjing 34
Shanghai 33
Helsinki 32
São Paulo 31
Taipei 29
Norwalk 27
Toronto 27
Boardman 24
Fremont 23
Padova 22
Brussels 21
Groningen 20
Bologna 18
Hefei 18
Hebei 16
Riverton 16
Duncan 15
Kunming 15
London 15
Ottawa 15
Philadelphia 15
Athens 14
Zhengzhou 14
Columbia 13
Hong Kong 13
New York 13
Brisbane 12
Como 12
Los Angeles 12
Rome 12
Chennai 11
Frankfurt am Main 11
Gainesville 11
Seoul 11
Florence 10
Munich 10
Toulouse 10
Upper Marlboro 10
Phoenix 9
Samsun 9
Urbana 9
Xian 9
Baton Rouge 8
Changsha 8
Edinburgh 8
Legnaro 8
Madrid 8
Mountain View 8
Nuremberg 8
Santiago 8
Silver Spring 8
Verona 8
Washington 8
Central District 7
Chengdu 7
Genoa 7
Hangzhou 7
Jinan 7
Kish 7
Leawood 7
Manhattan 7
Minneapolis 7
Pullman 7
Pune 7
Abuja 6
Burkardroth 6
Totale 7.561
Salva come PNG Salva come JPEG
Nome #
Metastatic cancer of unknown primary in 21 dogs 657
Minimal residual disease detection by flow cytometry and PARR in lymph node, peripheral blood and bone marrow, following treatment of dogs with diffuse large B-cell lymphoma 389
VEGF and MMP-9: biomarkers for canine lymphoma 344
CD44 in canine leukemia: Analysis of mRNA and proteinexpression in peripheral blood 314
Canine nodal marginal zone lymphoma: Descriptive insight into the biological behaviour 275
In vitro and in vivo effects of toceranib phosphate on canine osteosarcoma cell lines and xenograft orthotopic models 259
Evaluation of tyrosine-kinase receptor c-KIT (c-KIT) mutations, mRNA and protein expression in canine leukemia: Might c-KIT represent a therapeutic target? 234
Platelet-derived Growth Factors and Receptors in Canine Lymphoma 229
Expression of Matrix Metalloproteinases, Tissue Inhibitors of Metalloproteinases and Vascular Endothelial Growth Factor in Canine Mast Cell Tumours. 205
Flow-cytometric detection of phenotypic aberrancies in canine small clear cell lymphoma. 193
Epigenetic Silencing of TFPI-2 in Canine Diffuse Large B-Cell Lymphoma 190
Perspectives on the design of clinical trials for targeted therapies and immunotherapy in veterinary oncology 183
Severe renal failure in a dog resembling human focal segmental glomerulosclerosis. 175
DNA methylation profiling reveals common signatures of tumorigenesis and defines epigenetic prognostic subtypes of canine Diffuse Large B-cell Lymphoma 174
Matrix metalloproteinases and vascular endothelial growth factor expression in canine leukaemias 169
Evaluation of tyrosine-kinase receptor c-kit mutations, mRNA and protein expression in canine lymphoma: Might c-kit represent a therapeutic target? 155
Analytical and diagnostic validation of a flow cytometric strategy to quantify blood and marrow infiltration in dogs with large b-cell lymphoma 151
Epithelial mesenchymal transition in the progression of renal disease in dogs 143
The role of vascular endothelial growth factor and matrix metalloproteinases in canine lymphoma: in vivo and in vitro study 141
Peripheral blood lymphocyte/monocyte ratio as a useful prognostic factor in dogs with diffuse large B-cell lymphoma receiving chemoimmunotherapy 141
Dog as model for down-expression of E-cadherin and beta-catenin in tubular epithelial cells in renal fibrosis. 131
Canine small clear cell/T-zone lymphoma: Clinical presentation and outcome in a retrospective case series 125
Presenza del lisozima nel film lacrimale del gatto: dati preliminari. 122
Canine indolent and aggressive lymphoma: clinical spectrum with histologic correlation 122
Matrix metalloproteinases and their inhibitors in canine mammary tumors. 122
Anti-tumor activity of the dual BET and CBP/EP300 inhibitor NEO2734 121
Matrix metalloproteinases and their role in the renal epithelial mesenchymal transition 119
Flow cytometric evaluation of ki67 for the determination of malignancy grade in canine lymphoma. 118
Prognostic significance of Ki67 evaluated by flow cytometry in dogs with high-grade B-cell lymphoma 117
Bilateral juvenile renal dysplasia in a norvegian forest cat 114
Fido-SNP: the first webserver for scoring the impact of single nucleotide variants in the dog genome 110
Analisi istopatologica dei margini chirurgici in caso di fibrosarcoma vaccino-associato nel gatto e di mastocitoma nel cane 109
Aging in the Canine Kidney 109
Relationship of diagnostic accuracy of renal cortical echogenicity with renal histopathology in dogs and cats, a quantitative study 108
Immunofluorescence staining for detection of immunoglobulins and complement (C3) in dogs with renal disease 105
E-cadherin and beta-catenin expression in canine colorectal adenocarcinoma 104
Apoptosis in canine lymphomas and leukemias: preliminary results 103
The development of a recombinant scFv monoclonal antibody targeting canine CD20 for use in comparative medicine 102
A clinical report on enterolithiasis in horse in Italy 101
DETERMINATION OF PROLIFERATIVE ACTIVITY IN CANINE LEUKEMIAS BY FLOW CYTOMETRY 101
Flow cytometric detection of apoptotic cells in canine lymphoma 100
Aortic stenting in the growing sheep causes aortic endothelial dysfunction but not hypertension: Clinical implications for coarctation repair 100
The European canine lymphoma network: A joining initiative to generate consensus guidelines for the diagnosis and therapy in canine lymphoma and research partnership 98
Alterazioni macroscopiche e istologiche nel rene di bovino al macello 96
An Open-label Phase 1 Dose-escalation Clinical Trial of a Single Intravenous Administration of Gemcitabine in Dogs with Advanced Solid Tumors 94
CD3-CD20-positive nodal lymphoma with cross-lineage rearrangement in a dog 92
S-phase fraction determination in canine lymphoma 90
PROGNOSTIC VALUE OF KI67 IN CANINE LYMPHOMA DETERMINED BY FLOW CYTOMETRY 88
Transformation of Canine Lymphoma/Leukemia to More Aggressive Diseases: Anecdotes or Reality? 88
Adenocarcinoma of the disseminated prostate in a cat 86
E-caderina e beta-catenina down-expression nelle cellule tubulari epiteliali nelle patologie renali nel cane 83
Opportunities and challenges of active immunotherapy in dogs with B-cell lymphoma: A 5-year experience in two veterinary oncology centers 82
Diagnostic value of immunofluorescenceexam in canine kidney disease 80
Array-based comparative genomic hybridization analysis reveals chromosomal copy number aberrations associated with clinical outcome in canine diffuse large B-cell lymphoma 80
Histological and immunohistochemical characterization of feline renal cell carcinoma: a case series 79
Canine Lymphoma, More Than a Morphological Diagnosis: What We Have Learned about Diffuse Large B-Cell Lymphoma. 78
Clinical significance and in vitro cellular regulation of hypoxia mimicry on HIF-1α and downstream genes in canine appendicular osteosarcoma 78
Efficacy and side effects of radiation therapy in comparison with radiation therapy and temozolomide in the treatment of measurable canine malignant melanoma. 77
Prognostic significance of Ki67 evaluated by flow cytometry in dogs with high grade B-cell lymphoma 75
Loss of CD45 cell surface expression in canine T-zone lymphoma results from reduced gene expression 75
Canine necrotizing encephalitis associated with anti-glomerular basement membrane glomerulonephritis 74
Assessment of bone marrow infiltration diagnosed by flow cytometry in canine large B cell lymphoma: Prognostic significance and proposal of a cut-off value 73
Enhanced therapeutic effect of APAVAC immunotherapy in combination with dose-intense chemotherapy in dogs with advanced indolent B-cell lymphoma 73
Administration of Miltefosine and Meglumine Antimoniate in Healthy Dogs: Clinicopathological Evaluation of the Impact on the Kidneys 72
Adjuvant medical therapy provides no therapeutic benefit in the treatment of dogs with low-grade mast cell tumours and early nodal metastasis undergoing surgery 70
PROGNOSTIC SIGNIFICANCE OF KI67 EVALUATED BY FLO CYTOMETRY IN DOGS WITH HIGH GRADE B-CELL LYMPHOMA 69
Characterization of proteinuria in dogue de bordeaux dogs, a breed predisposed to a familial glomerulonephropathy: A retrospective study 69
Diagnostic methods for Helicobacter spp. detection in dog’s stomach. 69
Transizione epitelio-mesenchimale delle cellule tubulari renali nella glomerulonefrite membranosa e membrano-proliferativa del cane. 68
Validation of epigenetic mechanisms regulating gene expression in canine B-cell lymphoma: An in vitro and in vivo approach 68
Light and Electron Microscopic Analysis of Consecutive Renal Biopsy Specimens from Leishmania-Seropositive Dogs 67
From anemia to malignant histocytosis 66
VEGF E MMP-9 CROSS-TALK: POSSIBILI BIOMARCATORI NEL LINFOMA CANINO 62
A retrospective study of flow cytometric characterization of suspected extranodal lymphomas in dogs 62
X-Linked Hereditary Nephropathy in Navasota Dogs: Clinical Pathology, Morphology, and Gene Expression During Disease Progression 61
Molecole di adesione e metalloproteasi: indagine sul ruolo di CD44 e MMP-9 nelle neoplasie ematopoietiche canine 60
De novo expression of human leukocyte antigen-DR (HLA-DR) and loss of beta-catenin expression in tubular epithelial cells: A possible event in epithelial-mesenchymal transition in canine renal diseases 60
Mutational landscape of canine B-cell lymphoma profiled at single nucleotide resolution by RNA-seq 59
E-cadherin - β-catenin expression in canine colorectal adenocarcinoma: a suggested role upon local invasion. 58
New molecular and therapeutic insights into canine diffuse large B cell lymphoma elucidates the role of the dog as a model for human disease 56
A First NGS Investigation Suggests No Association Between Viruses and Canine Cancers 56
Longitudinal transcriptomic and genetic landscape of radiotherapy response in canine melanoma 55
Use of s-100 and chromogranin a antibodies as immunohistochemical markers on detection of malignancy in aortic body tumors in dog 55
PCNA overexpression in bovine experimentally treated with 17 beta estradiol 54
Genomic and Transcriptomic Characterization of Canine Osteosarcoma Cell Lines: A Valuable Resource in Translational Medicine 54
Evaluation of acute kidney injury in dogs with complicated or uncomplicated Babesia rossi infection 53
Long Non-Coding RNAs as Molecular Signatures for Canine B-Cell Lymphoma Characterization 53
Renal Morphology in Cats With Diabetes Mellitus 52
Phenotypical Characterization and Clinical Outcome of Canine Burkitt-Like Lymphoma 52
Hypermethylation-Mediated Silencing of CIDEA, MAL and PCDH17 Tumour Suppressor Genes in Canine DLBCL: From Multi-Omics Analyses to Mechanistic Studies 52
DNA methylation and targeted sequencing of methyltransferases family genes in canine acute myeloid leukaemia, modelling human myeloid leukaemia 51
Prognostic Value of PD-L1, PD-1 and CD8A in Canine Diffuse Large B-Cell Lymphoma Detected by RNAscope 51
Performance of lymph node cytopathology in diagnosis and characterization of lymphoma in dogs 51
Additional Value of Second Harmonic Generation Microscopy in the Diagnosis of Feline Collagen Type III Glomerulopathy 50
Valore diagnostico dell'esame di immunofluorescenza nelle biopsie renali del cane 49
Prognostic factors in canine acute leukaemias: A retrospective study 48
Diagnostic value of immunofluorescence exam in canine kidney biopsies 47
Epithelial-mesenchymal transition (EMT) of renal tubular cells in canine glomerulonephritis 45
European Veterinary Renal Pathology Service: A Survey Over a 7-Year Period (2008-2015) 45
The genomic landscape of canine diffuse large B-cell lymphoma identifies distinct subtypes with clinical and therapeutic implications 43
Totale 11.035
Salva come PNG Salva come JPEG
Categoria #
all - tutte 35.167
article - articoli 0
book - libri 0
conference - conferenze 4.883
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.050
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.214 0 0 0 0 0 233 224 177 215 162 104 99
2020/20211.779 85 204 202 116 141 128 112 107 148 200 83 253
2021/20221.456 86 86 59 102 93 44 92 115 65 153 238 323
2022/20231.994 259 133 45 201 159 481 180 132 161 67 107 69
2023/2024873 128 143 47 49 67 66 28 42 14 73 94 122
2024/20251.571 50 143 131 285 829 133 0 0 0 0 0 0
Totale 12.282